Display options
Share it on

Degener Neurol Neuromuscul Dis. 2012 Sep 04;2012(2). doi: 10.2147/DNND.S25750.

Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Degenerative neurological and neuromuscular disease

Nader Pouratian, Sandeep Thakkar, Won Kim, Jeff M Bronstein

Affiliations

  1. Departments of Neurosurgery, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles ; Bioengineering, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles.

PMID: 24298202 PMCID: PMC3843969 DOI: 10.2147/DNND.S25750

Abstract

Deep brain stimulation (DBS) surgery has become increasingly utilized in the treatment of advanced Parkinson's disease. Over the past decade, a number of studies have demonstrated that DBS is superior to best medical management in appropriately selected patients. The primary targets for DBS in Parkinson's disease include the subthalamic nucleus and the internal segment of the globus pallidus, both of which improve the cardinal motor features in Parkinson's disease. Recent randomized studies have revealed that both targets are similarly effective in treating the motor symptoms of Parkinson's disease, but emerging evidence suggests that the globus pallidus may be the preferred target in many patients, based on differences in nonmotor outcomes. Here, we review appropriate patient selection, and the efficacy and safety of DBS therapy in Parkinson's disease. Best outcomes are achieved if the problems of the individual patient are considered when evaluating surgical candidates and considering whether the subthalamic nucleus or the globus pallidus internus should be targeted.

Keywords: Parkinson’s disease; deep brain stimulation; dyskinesia; globus pallidus; subthalamic nucleus

References

  1. Mov Disord. 2006 Jun;21 Suppl 14:S219-37 - PubMed
  2. Neurology. 2012 Apr 3;78(14):1090-5 - PubMed
  3. J Neurosurg. 2007 Nov;107(5):998-1003 - PubMed
  4. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):952-4 - PubMed
  5. Arch Neurol. 2011 Feb;68(2):165 - PubMed
  6. Ann Neurol. 2011 Jul;70(1):5-8 - PubMed
  7. Lancet Neurol. 2012 May;11(5):429-42 - PubMed
  8. Confin Neurol. 1975;37(1-3):136-40 - PubMed
  9. Neurology. 2009 Nov 24;73(21):1746-51 - PubMed
  10. J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):358-63 - PubMed
  11. Brain. 2002 Nov;125(Pt 11):2408-17 - PubMed
  12. Neuroimage. 2009 Aug;47 Suppl 2:T44-52 - PubMed
  13. Stereotact Funct Neurosurg. 2006;84(2-3):64-71 - PubMed
  14. Mov Disord. 2008 Jul 15;23(9):1293-6 - PubMed
  15. J Neurosurg. 2009 Jun;110(6):1283-90 - PubMed
  16. Rev Neurol (Paris). 1953;89(6):578-80 - PubMed
  17. Parkinsonism Relat Disord. 2003 Dec;10(2):73-9 - PubMed
  18. Lancet Neurol. 2012 Feb;11(2):140-9 - PubMed
  19. Mov Disord. 2007 Sep 15;22(12):1722-8 - PubMed
  20. J Neurosurg. 2010 Jun;112(6):1271-6 - PubMed
  21. Arch Neurol. 2005 Aug;62(8):1250-5 - PubMed
  22. Acta Neurochir (Wien). 2012 Mar;154(3):481-94 - PubMed
  23. J Neurosurg. 2009 Feb;110(2):239-46 - PubMed
  24. Neurology. 2002 Sep 24;59(6):932-4 - PubMed
  25. Mayo Clin Proc. 2011 Jul;86(7):662-72 - PubMed
  26. Mov Disord. 2010 Apr 15;25(5):578-86 - PubMed
  27. Eur Neurol. 2006;55(3):136-44 - PubMed
  28. BMC Neurol. 2007 Mar 16;7:7 - PubMed
  29. Acta Neurochir (Wien). 2005 Oct;147(10):1061-4; discussion 1064 - PubMed
  30. AMA Arch Neurol Psychiatry. 1956 Jan;75(1):36-48 - PubMed
  31. Mov Disord. 2007 Jul 30;22(10):1457-1463 - PubMed
  32. World Neurosurg. 2010 Apr;73(4):338-44 - PubMed
  33. J Neurosurg. 2003 Apr;98(4):779-84 - PubMed
  34. J Neurosurg. 2011 Aug;115(2):310-5 - PubMed
  35. Mov Disord. 2011 Jul;26(8):1415-21 - PubMed
  36. Stereotact Funct Neurosurg. 1994;62(1-4):76-84 - PubMed
  37. Cereb Cortex. 2001 Dec;11(12):1136-43 - PubMed
  38. Int J Comput Assist Radiol Surg. 2012 Sep;7(5):687-704 - PubMed
  39. Lancet Neurol. 2010 Jun;9(6):581-91 - PubMed
  40. N Engl J Med. 2010 Jun 3;362(22):2077-91 - PubMed
  41. Mov Disord. 2006 Jun;21 Suppl 14:S305-27 - PubMed
  42. J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):789-95 - PubMed
  43. J Neurol Sci. 2007 Sep 15;260(1-2):199-203 - PubMed
  44. J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):175-82 - PubMed
  45. Neurosurgery. 1999 Dec;45(6):1375-82; discussion 1382-4 - PubMed
  46. J Neurosurg. 2012 Jan;116(1):84-94 - PubMed
  47. Ann Neurol. 2009 May;65(5):586-95 - PubMed
  48. Int J Speech Lang Pathol. 2010 Oct;12(5):375-84 - PubMed
  49. Neurosurgery. 2008 Nov;63(5):925-36; discussion 936-7 - PubMed
  50. Acta Neurochir (Wien). 2010 Dec;152(12):2053-62 - PubMed
  51. Brain. 2005 Oct;128(Pt 10):2240-9 - PubMed
  52. Stereotact Funct Neurosurg. 2006;84(5-6):248-51 - PubMed
  53. Mov Disord. 2008 Feb 15;23(3):416-21 - PubMed
  54. J Neurosurg. 2009 Feb;110(2):201-7 - PubMed
  55. Arch Neurol. 2001 Aug;58(8):1223-7 - PubMed
  56. Brain. 2008 Oct;131(Pt 10):2720-8 - PubMed
  57. Brain Stimul. 2012 Oct;5(4):625-33 - PubMed
  58. Brain Cogn. 2000 Apr;42(3):324-47 - PubMed
  59. N Engl J Med. 2006 Aug 31;355(9):896-908 - PubMed
  60. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S165-7 - PubMed
  61. Nervenarzt. 1954 Nov 20;25(11):441-7 - PubMed
  62. Neurology. 2010 Oct 5;75(14):1292-9 - PubMed
  63. J Neurol Sci. 2008 Oct 15;273(1-2):135-8 - PubMed
  64. Neurosurgery. 2008 Feb;62(2):360-6; discussion 366-7 - PubMed
  65. Neurosurgery. 2011 Aug;69(2):294-9; discussion 299-300 - PubMed
  66. J Neurosurg. 1992 Jan;76(1):53-61 - PubMed
  67. Neurology. 2001 Feb 27;56(4):548-51 - PubMed
  68. Ann Neurol. 2002 Feb;51(2):156-64 - PubMed
  69. Neurosurgery. 2009 Dec;65(6 Suppl):196-201; discussion 201-2 - PubMed
  70. Neurology. 2007 Apr 24;68(17):1345-55 - PubMed
  71. Neurology. 2002 Nov 12;59(9):1427-9 - PubMed
  72. Mov Disord. 2008 Feb 15;23(3):343-9 - PubMed
  73. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):701-7 - PubMed
  74. Brain. 2010 Jan;133(Pt 1):215-24 - PubMed
  75. Lancet Neurol. 2008 Jul;7(7):605-14 - PubMed
  76. Neurosurg Clin N Am. 2011 Apr;22(2):197-206, viii - PubMed
  77. Arch Neurol. 2005 Apr;62(4):554-60 - PubMed
  78. Parkinsonism Relat Disord. 2009 Sep;15(8):587-91 - PubMed
  79. Mov Disord. 2006 Jun;21 Suppl 14:S171-96 - PubMed
  80. JAMA. 2009 Jan 7;301(1):63-73 - PubMed
  81. Acta Neurochir (Wien). 2009 Jan;151(1):31-6 - PubMed
  82. Neurology. 2012 Jul 3;79(1):55-65 - PubMed
  83. Stereotact Funct Neurosurg. 2008;86(6):337-44 - PubMed
  84. Mov Disord. 2002;17 Suppl 3:S188-97 - PubMed
  85. Lab Chip. 2012 Jan 21;12(2):361-8 - PubMed
  86. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):834-9 - PubMed
  87. J Neurosurg. 2009 Feb;110(2):247-50 - PubMed
  88. Neurology. 2008 May 20;70(21):1991-5 - PubMed
  89. J Neurol. 2007 Feb;254(2):169-78 - PubMed
  90. Neurology. 2011 Jan 4;76(1):80-6 - PubMed
  91. Stereotact Funct Neurosurg. 2011;89(6):357-64 - PubMed
  92. Arch Clin Neuropsychol. 2004 Mar;19(2):165-81 - PubMed
  93. J Neurosci Methods. 2011 Jun 15;198(2):280-6 - PubMed
  94. Ann Neurol. 1999 Aug;46(2):217-23 - PubMed
  95. Parkinsonism Relat Disord. 2006 Jun;12(5):265-72 - PubMed
  96. Neuroimage. 2012 Mar;60(1):83-94 - PubMed
  97. N Engl J Med. 2003 Nov 13;349(20):1925-34 - PubMed
  98. Neurology. 2006 Apr 11;66(7):983-95 - PubMed
  99. Stereotact Funct Neurosurg. 2010;88(3):147-55 - PubMed
  100. Brain. 2004 Sep;127(Pt 9):2131-43 - PubMed
  101. Neurology. 2008 Jul 8;71(2):80-4 - PubMed
  102. Parkinsonism Relat Disord. 2010 Feb;16(2):115-8 - PubMed

Publication Types

Grant support